American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases-Reference-Cited by-同舟云学术

American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases

Published:2017-09 Issue:3 Volume:153 Page:835-857.e6
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Vande Casteele Niels,Herfarth Hans,Katz Jeffry,Falck-Ytter Yngve,Singh Siddharth

Funder

National Library of Medicine training

American College of Gastroenterology and Crohn’s and Colitis Foundation

National Institutes of Health

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference88 articles.

1. Management strategies to improve outcomes of patients with inflammatory bowel diseases;Colombel;Gastroenterology,2017

2. Therapeutic drug monitoring in inflammatory bowel disease: current state and future perspectives;Vande Casteele;Curr Gastroenterol Rep,2014

3. Therapeutic drug monitoring of anti-tumor necrosis factor agents in patients with inflammatory bowel diseases;Yarur;Inflamm Bowel Dis,2015

4. Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel disease;Afif;Am J Gastroenterol,2010

5. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease;Dubinsky;Gastroenterology,2002

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prediction method for the individual serum concentration and therapeutic effect for optimizing adalimumab therapy in inflammatory bowel disease;Journal of Pharmacy and Pharmacology;2024-07-15

2. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study;The Lancet Gastroenterology & Hepatology;2024-06

3. Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease;Clinics and Research in Hepatology and Gastroenterology;2024-06

4. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05

5. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis;Gastroenterología y Hepatología (English Edition);2024-05